The Philadelphia variant of galactokinase in human erythrocytes: physicochemical and catalytic properties.
The Philadelphia variant of galactokinase (GALKP) is responsible for an asymptomatic disorder of galactose metabolism. Individuals with GALKP phenotype are common among black people. They exhibit reduced galactokinase (GALK) activity in their red blood cells but normal activity in their white blood cells. We explored the biochemical characteristics of hemolysates from individuals with the GALKP phenotype and from controls. In mixed hemolysates from a control and a proband, the GALK activity measured did not suggest the presence of an inhibitor. We observed that the catalytic properties, pI and thermolability in hemolysates from controls and GALKP individuals were identical. Thus, the Philadelphia variant of galactokinase seems not to alter biochemical properties of the red blood cell enzyme. A silent amino acid substitution, or the dysfunction of a regulatory gene might be likely suggested to explain the reduced enzyme activity.
Soni
T
T
Laboratoire de Biochimie, Hôpital Bicêtre, Paris, France.
Brivet
M
M
Moatti
N
N
Lemonnier
A
A
D044383:Black People; D002384:Catalysis; D004912:Erythrocytes / Q000201:enzymology*; D005686:Galactokinase / Q000097:blood / Q000235:genetics* / Q000302:isolation & purification; D006358:Hot Temperature; D006801:Humans; D007525:Isoelectric Focusing; D010641:Phenotype
D005686:Galactokinase